Product Details for NDA 020358
WELLBUTRIN SR (BUPROPION HYDROCHLORIDE)
100MG
Marketing Status: Prescription
150MG
Marketing Status: Prescription
200MG
Marketing Status: Prescription
50MG
Marketing Status: Discontinued
100MG
Marketing Status: Prescription
Active Ingredient: BUPROPION HYDROCHLORIDE
Proprietary Name: WELLBUTRIN SR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 100MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB1
Application Number: N020358
Product Number: 002
Approval Date: Oct 4, 1996
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status: Prescription
Patent and Exclusivity Information
WELLBUTRIN SR (BUPROPION HYDROCHLORIDE)
Proprietary Name: WELLBUTRIN SR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 100MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB1
Application Number: N020358
Product Number: 002
Approval Date: Oct 4, 1996
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status: Prescription
Patent and Exclusivity Information
150MG
Marketing Status: Prescription
Active Ingredient: BUPROPION HYDROCHLORIDE
Proprietary Name: WELLBUTRIN SR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 150MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB1
Application Number: N020358
Product Number: 003
Approval Date: Oct 4, 1996
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status: Prescription
Patent and Exclusivity Information
WELLBUTRIN SR (BUPROPION HYDROCHLORIDE)
Proprietary Name: WELLBUTRIN SR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 150MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB1
Application Number: N020358
Product Number: 003
Approval Date: Oct 4, 1996
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status: Prescription
Patent and Exclusivity Information
200MG
Marketing Status: Prescription
Active Ingredient: BUPROPION HYDROCHLORIDE
Proprietary Name: WELLBUTRIN SR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 200MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB1
Application Number: N020358
Product Number: 004
Approval Date: Jun 14, 2002
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status: Prescription
Patent and Exclusivity Information
WELLBUTRIN SR (BUPROPION HYDROCHLORIDE)
Proprietary Name: WELLBUTRIN SR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 200MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB1
Application Number: N020358
Product Number: 004
Approval Date: Jun 14, 2002
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status: Prescription
Patent and Exclusivity Information
50MG
Marketing Status: Discontinued
Active Ingredient: BUPROPION HYDROCHLORIDE
Proprietary Name: WELLBUTRIN SR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 50MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N020358
Product Number: 001
Approval Date: Oct 4, 1996
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: WELLBUTRIN SR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 50MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N020358
Product Number: 001
Approval Date: Oct 4, 1996
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status: Discontinued
Patent and Exclusivity Information